307 related articles for article (PubMed ID: 29426008)
1. Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial.
Leung YY; Haaland B; Huebner JL; Wong SBS; Tjai M; Wang C; Chowbay B; Thumboo J; Chakraborty B; Tan MH; Kraus VB
Osteoarthritis Cartilage; 2018 May; 26(5):631-640. PubMed ID: 29426008
[TBL] [Abstract][Full Text] [Related]
2. Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): study protocol for a randomized controlled trial.
Leung YY; Thumboo J; Wong BS; Haaland B; Chowbay B; Chakraborty B; Tan MH; Kraus VB
Trials; 2015 Apr; 16():200. PubMed ID: 25925674
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain.
Leung YY; Huebner JL; Haaland B; Wong SBS; Kraus VB
Osteoarthritis Cartilage; 2017 Sep; 25(9):1420-1427. PubMed ID: 28433814
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis.
Cole BJ; Karas V; Hussey K; Pilz K; Fortier LA
Am J Sports Med; 2017 Feb; 45(2):339-346. PubMed ID: 28146403
[TBL] [Abstract][Full Text] [Related]
5. Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation.
Haraden CA; Huebner JL; Hsueh MF; Li YJ; Kraus VB
Arthritis Res Ther; 2019 Jun; 21(1):146. PubMed ID: 31196179
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose oral prednisolone on symptoms and systemic inflammation in older adults with moderate to severe knee osteoarthritis: a randomized placebo-controlled trial.
Abou-Raya A; Abou-Raya S; Khadrawi T; Helmii M
J Rheumatol; 2014 Jan; 41(1):53-9. PubMed ID: 24293578
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial.
McAlindon T; LaValley M; Schneider E; Nuite M; Lee JY; Price LL; Lo G; Dawson-Hughes B
JAMA; 2013 Jan; 309(2):155-62. PubMed ID: 23299607
[TBL] [Abstract][Full Text] [Related]
8. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial.
Kon E; Engebretsen L; Verdonk P; Nehrer S; Filardo G
Am J Sports Med; 2018 Jan; 46(1):171-180. PubMed ID: 29016185
[TBL] [Abstract][Full Text] [Related]
10. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
11. CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.
Jin Y; Smith C; Monteith D; Brown R; Camporeale A; McNearney TA; Deeg MA; Raddad E; Xiao N; de la Peña A; Kivitz AJ; Schnitzer TJ
Osteoarthritis Cartilage; 2018 Dec; 26(12):1609-1618. PubMed ID: 30240937
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report.
Das SK; Ramakrishnan S; Mishra K; Srivastava R; Agarwal GG; Singh R; Sircar AR
Arthritis Rheum; 2002 Jun; 47(3):280-4. PubMed ID: 12115158
[TBL] [Abstract][Full Text] [Related]
13. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis.
Li L; Li Z; Li Y; Hu X; Zhang Y; Fan P
BMC Musculoskelet Disord; 2020 Feb; 21(1):99. PubMed ID: 32059658
[TBL] [Abstract][Full Text] [Related]
14. Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial.
Zhu Z; Yu Q; Leng X; Han W; Li Z; Huang C; Gu J; Zhao Y; Wang K; Li T; Mei Y; Xu J; Zhang Z; Hunter D; Cicuttini F; Zeng X; Ding C
Trials; 2020 Sep; 21(1):795. PubMed ID: 32938470
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee.
Das SK; Mishra K; Ramakrishnan S; Srivastava R; Agarwal GG; Singh R; Sircar AR
Osteoarthritis Cartilage; 2002 Apr; 10(4):247-52. PubMed ID: 11950246
[TBL] [Abstract][Full Text] [Related]
16. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
[TBL] [Abstract][Full Text] [Related]
17. A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.
Geusens P; Pavelka K; Rovensky J; Vanhoof J; Demeester N; Calomme M; Vanden Berghe D
BMC Musculoskelet Disord; 2017 Jan; 18(1):2. PubMed ID: 28056936
[TBL] [Abstract][Full Text] [Related]
18. Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial.
Lao L; Hochberg M; Lee DYW; Gilpin AMK; Fong HHS; Langenberg P; Chen K; Li EK; Tam LS; Berman B
Osteoarthritis Cartilage; 2015 Dec; 23(12):2102-2108. PubMed ID: 26099553
[TBL] [Abstract][Full Text] [Related]
19. Rubus idaeus extract improves symptoms in knee osteoarthritis patients: results from a phase II double-blind randomized controlled trial.
Henrotin Y; Cozannet RL; Fança-Berthon P; Truillet R; Cohen-Solhal M; DunnGalvin G; Grouin JM; Doolan A
BMC Musculoskelet Disord; 2022 Jul; 23(1):650. PubMed ID: 35799169
[TBL] [Abstract][Full Text] [Related]
20. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
